XRP Adoption Expands to 6,000 US Pharmacies
NewsWellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.

- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.

The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
Sky USDS Reportedly Shrinks 35% as $1.5B Leaves Reserves
The outflow hit Sky’s Peg Stability Module (PSM), the mechanism that allows users to swap USDS one-for-one with USDC.
1inch Reportedly Taps Hyperliquid for Perpetual Futures Trading
According to The Block’s report on the announcement, the integration routes positions through Hyperliquid’s on-chain order book.
Why Is Zcash (ZEC) Price Down Today?
Zcash (ZEC) is trading at $919.86, down 3.12% over the past 24 hours, according to CoinGecko data as of 04:00 UTC on November 19, 2026.
Binance Says It Is Discussing Expansion Into 5 Asian Markets
Seker told Reuters that Binance has “ongoing conversations with at least five or six markets, three of which are in quite mature stages. ” The exchange declined...
Why Is Aster (ASTER) Price Down Today?
Aster (ASTER) is trading at $0.5632, down 3.04% in the past 24 hours, according to CoinGecko data as of 02:28 UTC on November 18, 2026 .
Why Is Injective (INJ) Price Up Today?
In its official X announcement , Injective Protocol wrote: “INJ is on Nasdaq. $INJC, the first US ETF for $INJ, went live Thursday with staking built in, and on...